Dhuwit awis perusahaan: CRISPR Therapeutics AG (CRSP)

CRSP (CRISPR Therapeutics) - tandha merek perusahaan

CRISPR Therapeutics AG (CRSP) is a gene-editing leader holding patents for the CRISPR/Cas9 method and the successful drug Casgevy. On GURU.Markets, the company's cash reserves demonstrate liquidity for M&A transactions, with the parameter stabilizing at 2.26. However, the high cost of therapy and R&D expenditures create financial pressure, despite the company's flawless image as an innovator in the eyes of the global scientific community.

CRISPR Therapeutics Inc - Gunggung dana dhuwit perusahaan CRSP (periode 04.07.2022 - 21.11.2026)

Rincian metrik lan analitis perusahaan CRISPR Therapeutics Inc (CRSP)

- indikator kapitalisasi bursa perusahaan:
Analisis dhasar perusahaan:CRISPR Therapeutics AG CRSP
Produk merek CRISPR Therapeutics

When constructing a long-term portfolio, it is critical to assess liquidity via free cash flow, which determines an issuer's ability to fund development without resorting to expensive debt capital. This metric measures the net cash balance, which in the case of CRISPR Therapeutics AG (CRSP) confirms a transition toward self-sufficiency through drug commercialization, while the trend in cash assets illustrates the current resilience of the business.

Pesaing langsung

Volume dana dhuwit perusahaan TEM|QGEN - Cadangan dhuwit perusahaan|ionispharma.com - Dhuwit awis perusahaan|Sisa dhuwit perusahaan RGEN|Avidity Corp - Volume dana dhuwit perusahaan|GeneDx Corp (WGS) - Dhuwit awis perusahaan|RARE: Volume dana dhuwit perusahaan|BEAM - Aset likuid perusahaan|SRPT (Sarepta Therapeutics) - Volume dana dhuwit perusahaan|Dhuwit awis perusahaan Twist Bioscience Inc (TWST)|Volume dana dhuwit perusahaan TXG|Aset likuid perusahaan Intellia|Stoke - Dhuwit awis perusahaan|BLFS: Dhuwit awis lan setara dhuwit awis perusahaan|Wave Life Sciences Corp - Volume dana dhuwit perusahaan|Maze Therapeutics, Inc. (MAZE) - Dhuwit awis perusahaan|Sionna Therapeutics Inc (SION) - Dana dhuwit perusahaan|Dhuwit awis perusahaan Prime Medicine Corp|Dana dhuwit perusahaan tayshagtx.com|QURE - Posisi dhuwit perusahaan|Dhuwit awis perusahaan MGTX (MeiraGTx Holdings plc)|REGENXBIO (RGNX) - Posisi dhuwit perusahaan|Volume dana dhuwit perusahaan SLDB (Solid Biosciences Inc.)|Sisa dhuwit perusahaan OCGN|PacBio Corp - Volume dana dhuwit perusahaan|Benitec Biopharma Inc. (BNTC) - Dhuwit awis perusahaan|DSGN: Volume dana dhuwit perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan RCKT|Dhuwit awis perusahaan FDMT|Dhuwit awis lan setara dhuwit awis perusahaan LXEO (Lexeo Therapeutics)|Volume dana dhuwit perusahaan KRRO|Editas Medicine, Inc. - Dhuwit awis lan setara dhuwit awis perusahaan|Dana dhuwit perusahaan Silence Therapeutics Inc. SLN|Volume dana dhuwit perusahaan ProQR Therapeutics N.V. PRQR|CDXS: Dhuwit awis perusahaan|Posisi dhuwit perusahaan Sangamo (SGMO)|NAUT (Nautilus Bio) - Dhuwit awis perusahaan|MGX - Aset likuid perusahaan|DTIL (Precision BioSciences Inc.) - Volume dana dhuwit perusahaan|generationbio.com (GBIO) - Aset likuid perusahaan|Dana dhuwit perusahaan Boundless Bio Inc (BOLD)|Volume dana dhuwit perusahaan Exicure Inc. (XCUR)|Dana dhuwit perusahaan imunon.com IMNN|Volume dana dhuwit perusahaan Phio Pharmaceuticals PHIO|Mustang Bio Inc - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan transcodetherapeutics.com|BNGO: Volume dana dhuwit perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan APDN|BLUE (bluebirdbio.com) - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan ImmunoPrecise Antibodies IPA|Dhuwit awis perusahaan OMGA (omegatherapeutics.com)|Volume dana dhuwit perusahaan Singular Genomics Systems, Inc. (OMIC)|Volume dana dhuwit perusahaan RGLS (Regulus Therapeutics, Inc.)|Volume dana dhuwit perusahaan Syros SYRS|Telesis Bio, Inc. - Volume dana dhuwit perusahaan|TRACON Pharmaceuticals (TCON) - Dhuwit awis perusahaan|UBX: Volume dana dhuwit perusahaan